78 related articles for article (PubMed ID: 10683370)
1. Signaling in leukemia: which messenger to kill?
Pear WS
J Clin Invest; 2000 Feb; 105(4):419-22. PubMed ID: 10683370
[No Abstract] [Full Text] [Related]
2. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.
Tomasson MH; Sternberg DW; Williams IR; Carroll M; Cain D; Aster JC; Ilaria RL; Van Etten RA; Gilliland DG
J Clin Invest; 2000 Feb; 105(4):423-32. PubMed ID: 10683371
[TBL] [Abstract][Full Text] [Related]
3. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.
Okuda K; Golub TR; Gilliland DG; Griffin JD
Oncogene; 1996 Sep; 13(6):1147-52. PubMed ID: 8808688
[TBL] [Abstract][Full Text] [Related]
4. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways.
Carroll M; Tomasson MH; Barker GF; Golub TR; Gilliland DG
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14845-50. PubMed ID: 8962143
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the TEL gene in hematologic malignancy by diverse molecular genetic mechanisms.
Golub TR; Barker GF; Stegmaier K; Gilliland DG
Curr Top Microbiol Immunol; 1996; 211():279-88. PubMed ID: 8585959
[No Abstract] [Full Text] [Related]
6. ETV6: a versatile player in leukemogenesis.
Bohlander SK
Semin Cancer Biol; 2005 Jun; 15(3):162-74. PubMed ID: 15826831
[TBL] [Abstract][Full Text] [Related]
7. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.
Golub TR; Barker GF; Lovett M; Gilliland DG
Cell; 1994 Apr; 77(2):307-16. PubMed ID: 8168137
[TBL] [Abstract][Full Text] [Related]
8. Frequency of ETV6/AML1 fusion in adult acute lymphoblastic leukemia.
Cuneo A; Agostini P; Vitale A; Foà R; Castoldi G
Leukemia; 2003 Feb; 17(2):476-7; author reply 477. PubMed ID: 12592356
[No Abstract] [Full Text] [Related]
9. Specific induction of CD33 expression by E2A-HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor.
Akahane K; Inukai T; Inaba T; Kurosawa H; Look AT; Kiyokawa N; Fujimoto J; Goto H; Endo M; Zhang X; Hirose K; Kuroda I; Honna H; Kagami K; Goi K; Nakazawa S; Sugita K
Leukemia; 2010 Apr; 24(4):865-9. PubMed ID: 20147975
[No Abstract] [Full Text] [Related]
10. TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K
Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275
[TBL] [Abstract][Full Text] [Related]
11. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
[TBL] [Abstract][Full Text] [Related]
12. Detection of ETV6/MDS1/Evi-1 chimeric transcripts in a patient with acute myelocytic leukemia and t(3;12)(q26;p13).
Nishimura Y; Wada H; Mori A; Takatsuka H; Tamura A; Fujimori Y; Okamoto T; Takemoto Y; Kakishita E
Int J Hematol; 2000 Jul; 72(1):108-9. PubMed ID: 10979219
[No Abstract] [Full Text] [Related]
13. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
[TBL] [Abstract][Full Text] [Related]
14. TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia.
Raynaud S; Mauvieux L; Cayuela JM; Bastard C; Bilhou-Nabera C; Debuire B; Bories D; Boucheix C; Charrin C; Fière D; Gabert J
Leukemia; 1996 Sep; 10(9):1529-30. PubMed ID: 8751475
[No Abstract] [Full Text] [Related]
15. Protein tyrosine kinases and cancer.
Kolibaba KS; Druker BJ
Biochim Biophys Acta; 1997 Dec; 1333(3):F217-48. PubMed ID: 9426205
[No Abstract] [Full Text] [Related]
16. Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells.
Racanicchi S; Maccherani C; Liberatore C; Billi M; Gelmetti V; Panigada M; Rizzo G; Nervi C; Grignani F
EMBO J; 2005 Mar; 24(6):1232-42. PubMed ID: 15729358
[TBL] [Abstract][Full Text] [Related]
17. Analysis of TEL proteins in human leukemias.
Poirel H; Lacronique V; Mauchauffé M; Le Coniat M; Raffoux E; Daniel MT; Erickson P; Drabkin H; MacLeod RA; Drexler HG; Ghysdael J; Berger R; Bernard OA
Oncogene; 1998 Jun; 16(22):2895-903. PubMed ID: 9671410
[TBL] [Abstract][Full Text] [Related]
18. A rare case of acute myeloid leukemia with a CHIC2-ETV6 fusiongen and multiple other molecular aberrations.
Kuchenbauer F; Schoch C; Holler E; Haferlach T; Hiddemann W; Schnittger S
Leukemia; 2005 Dec; 19(12):2366-8. PubMed ID: 16224488
[No Abstract] [Full Text] [Related]
19. Signal transduction and the Ets family of transcription factors.
Yordy JS; Muise-Helmericks RC
Oncogene; 2000 Dec; 19(55):6503-13. PubMed ID: 11175366
[TBL] [Abstract][Full Text] [Related]
20. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD
Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]